On Tuesday, the U.S. Food and Drug Administration’s advisory committee voted to back Pfizer's vaccine for kids ages 5 to 11.
The vaccine could be available for some 28 million children by next week.
Dr. Bian Labus, an infectious disease specialist with UNLV tells 13 Action News the decision is a game changer, especially because these kids are in school.
FDA Authorizes , Pfizer’s COVID-19 Vaccine, for Kids Ages 5 to 11.
On October 29, the Food and Drug Administration gave..
FDA Panel Reviewing, Pfizer Clinical Trial, For Children 5 and Up.
On October 26, a Food and Drug Administration advisory..
